Clinical Trial Update: Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN ) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating patritumab with cetuximab and a platinum agent for head and neck squamous cell carcinoma has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasms
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• patritumab (patritumab)
• platinum agent (platinum-based chemotherapy)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Head and Neck Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2019-01-07